Aziza T. Shad, MD
Chief, Division of Pediatric Hematology/Oncology, Blood, and Bone Marrow Transplantation
Amey Distinguished Professor of Neuro-Oncology and Childhood Cancer
Dr. Aziza Shad
Aziza Shad, MD, graduated with honors from Dow Medical College, Karachi, Pakistan in 1977. After completing a residency in Pediatrics, she obtained a Post-Graduate Diploma in Child Health (DCH) from the University of Karachi, Pakistan in 1980. After additional training in Pediatrics and Oncology in London, UK, she completed another Pediatric Residency at the Children's Hospital, Pennsylvania State University, Hershey, PA, (1986-89), followed by a Fellowship in Pediatric Hematology/Oncology at the National Cancer Institute, NIH, Bethesda, MD, (1989-92). She continued her work on Pediatric Lymphomas for an additional three years as a Visiting Scientist in the Lymphoma Biology Section at the NCI.
Dr. Shad joined the Division of Pediatric Hematology Oncology, Georgetown University, as an Assistant Professor in Pediatrics in November 1995. Dr. Shad is Board certified in Pediatrics and Pediatric Hematology Oncology. She is currently Professor of Pediatrics and Oncology, and the Chief of the Division of Pediatric Hematology Oncology, Blood and Marrow Transplantation, Lombardi Comprehensive Cancer Center, Georgetown University Hospital. She is also the Director of the Leukemia Lymphoma Program and Director of the Cancer Survivorship Program. In addition, she is actively involved in the development of Pediatric Oncology Programs in Developing Countries, particularly in Asia, the Middle East, Africa and Latin America.
Dr. Shad is the Director of the US branch of INCTR (International Network for Cancer Treatment and Research), Chair of the Pediatric Oncology Education Committee and Member of the Governing Council of the INCTR. She is also a Senior Scientific Advisor for the International Committee for Establishment and Development of Oncology Centers (ICEDOC) and Chair of the Palliative Care Steering Committee for MECC (Middle East Cancer Consortium).
She has spoken at numerous scientific meetings, both nationally and internationally, and has published in the field of Pediatric Lymphomas, Pediatric Oncology in Developing Countries and Late Effects in Cancer Survivors, a major area of her research.